Get started
Author

J.R. Penrod

The McGill Consensus Statement on Overdentures Mandibular two‐implant overdentures as first choice standard of care for edentulous patients
2002 · JS Feine, GE Carlsson, et al. · Gerodontology · 757
The McGill consensus statement on overdentures.
2003 · Feine Js, Carlsson Ge, et al. · PubMed · 534
The McGill consensus statement on overdentures. Mandibular two-implant overdentures as first choice standard of care for edentulous patients. Montreal, Quebec, May 24-25, 2002
2002 · JS Feine, GE Carlsson, et al. · PubMed · 273
The McGill Consensus Statement on Overdentures. Montreal, Quebec, Canada. May 24-25, 2002
2002 · JS Feine, GE Carlsson, et al. · PubMed · 194
Cost-effectiveness of Mandibular Two-implant Overdentures and Conventional Dentures in the Edentulous Elderly
2005 · G. Heydecke, J.R. Penrod, et al. · Journal of Dental Research · 125
Estimation of Direct and Indirect Costs Because of Common Infections in Toddlers Attending Day Care Centers
1999 · H. Carabin, T. W. Gyorkos, et al. · PEDIATRICS · 103
A cost comparison of mandibular two-implant overdenture and conventional denture treatment
2004 · Y Takanashi, J.R Penrod, et al. · Journal of Prosthetic Dentistry · 90
An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group.
1999 · A E Clarke, M A Petri, et al. · PubMed · 59
Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group.
2000 · A E Clarke, J Penrod, et al. · PubMed · 54
Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
2001 · A E Clarke, Y St-Pierre, et al. · PubMed · 53
The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being
2005 · P. Panopalis, M. Petri, et al. · Lara D. Veeken · 51
1243P Pathologic response as early endpoint for survival following neoadjuvant therapy (NEO-AT) in resectable non-small cell lung cancer (rNSCLC): Systematic literature review and meta-analysis
2020 · N.A. Waser, A. Adam, et al. · Annals of Oncology · 49
PDF
Co-morbidity and physician use in fibromyalgia
2005 · S Bernatsky, PL Dobkin, et al. · Swiss Medical Weekly · 44
Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis.
1999 · A E Clarke, C Levinton, et al. · PubMed · 43
3011 Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017
2015 · M. Reck, C. Coon, et al. · European Journal of Cancer · 16
Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up
2022 · M. A. Chaudhary, M. Edmondson-Jones, et al. · Medical Decision Making · 13
PDF
MO01.02 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab in the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the United States
2021 · M. Berling, M.A. Chaudhary, et al. · Journal of Thoracic Oncology · 10
O.02 Long-term Survival Outcomes with Nivolumab (NIVO) in Pts with Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC): Impact of Early Disease Control and Response
2019 · J. Brahmer, L. Horn, et al. · Journal of Thoracic Oncology · 9
PDF
Overall health status (HS) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC treated with nivolumab (nivo) or docetaxel (doc) in CheckMate 057
2016 · M. Reck, J.R. Brahmer, et al. · Annals of Oncology · 8
PDF
460P Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017
2015 · M. Reck, C. Coon, et al. · Annals of Oncology · 6
PDF
Evolution of overall survival (OS) in patients (pts) with incident NSCLC in Denmark and Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative
2019 · J.B. Sørensen, S. Ekman, et al. · Annals of Oncology · 5
PDF
Clinical characteristics and overall survival of patients diagnosed with non-small cell lung cancer (NSCLC) between 2006 and 2017 in routine clinical practice: a retrospective analysis of a UK hospital database
2018 · M. Snee, S. Cheeseman, et al. · Lung Cancer · 5
P1.12-21 Developing a Real-World 3L Comparator to CheckMate 032: Overall Survival (OS) in Patients with Small Cell Lung Cancer (SCLC)
2018 · L. Schwartzberg, B. Korytowsky, et al. · Journal of Thoracic Oncology · 4
PDF
Assessing the Burden of Caregiving for Patients with Lung Cancer in Europe
2013 · A. Goren, I. Gilloteau, et al. · Value in Health · 3
PSS28 Economic Burden of Advanced Melanoma: Findings From A Large US Health Insurance Database
2011 · G. Oster, C. Taneja, et al. · Value in Health · 3
Works count: 81
Citation count: 2,540
H-index: 15
I10-index: 17
Year
Topic
Type